MultiDrug Resistance (MDR) is the major obstacle to a successful cancer therapy and is often associated with an increased efflux of anticancer drugs due to some proteins belonging to the ATP-Binding Cassette (ABC) transporters family such as P-gp, BCRP and MRP1 [1,2,3,4,5]. The gene discussed is ABCG2; the disease is cancer.